ArticleRMD open2017

Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis.

D H Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.